Aishwarya Nene

Aishwarya Nene

Auto-generated profile, based on publicly available information

Aishwarya Nene

Department of Internal Medicine, University of California San Francisco School of Medicine (A.N.).

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Cell Stem Cell
Verified
Journal Article
Closed access
MBMarina Bershteyn
Marina Bershteyn
TNTomasz J. Nowakowski
Tomasz J. Nowakowski
APAlex A. Pollen
Alex A. Pollen
ELElizabeth Di Lullo
Elizabeth Di Lullo
ANAishwarya Nene
Aishwarya Nene
AKArnold R. Kriegstein
Arnold R. Kriegstein

13 January 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ALAlexander X. Lozano
Alexander X. Lozano
ACAadel A. Chaudhuri
Aadel A. Chaudhuri
ANAishwarya Nene
Aishwarya Nene
ABAntonietta Bacchiocchi
Antonietta Bacchiocchi
NENoah Earland
Noah Earland
ANAaron M. Newman
Aaron M. Newman

15 October 2013 in PLOS Biology
Verified
Journal Article
Open access
PDF file
HMHiruy S. Meharena
Hiruy S. Meharena
PCPhilip Chang
Philip Chang
MKMalik M. Keshwani
Malik M. Keshwani
KOKrishnadev Oruganty
Krishnadev Oruganty
ANAishwarya K. Nene
Aishwarya K. Nene
AKAlexandr Kornev
Alexandr Kornev
Eukaryotic protein kinases (EPKs) regulate numerous signaling processes by phosphorylating targeted substrates through the highly conserved catalytic domain. Our previous computational studies proposed a model stating that a properly assembled nonlinear motif termed the Regulatory (R) spine is essential for catalytic activity of EPKs. Here we define the required intramolecular interactions and biochemical properties of the R-spine and the newly identified “Shell” that surrounds the R-spine using site-directed mutagenesis and various in vitro phosphoryl transfer assays using cyclic AMP-dependent protein kinase as a representative of the entire kinome. Analysis of the 172 available Apo EPK structures in the protein data bank (PDB) revealed four unique structural conformations of the R-spine that correspond with catalytic inactivation of various EPKs. Elucidating the molecular entities required for the catalytic activation of EPKs and the identification of these inactive conformations opens new avenues for the design of efficient therapeutic EPK inhibitors. Eukaryotic protein kinases (EPKs) have a highly conserved enzymatic kinase core that is involved in the regulation of numerous cell signaling processes through the transfer of a phosphate group from adenosine triphosphate (ATP) to more than 30% of human proteins. EPKs have been implicated in numerous human diseases, including cancer, cardiovascular diseases, and diabetes, making them one of the most sought-after therapeutic drug targets. The lack of structural diversity of the active kinase core has created a bottle-neck for designing successful therapeutic inhibitors. Here we describe the intramolecular interactions required for differentiating between the active and inactive states of EPKs. Kinases contain a hydrophobic regulatory spine (“R-spine”) that is disassembled in inactive kinases, and here we define an additional hydrophobic “Shell” that surrounds one end of the R-spine. Biochemical analysis of the five nonconsecutive R-spine residues and three nonconsecutive Shell residues shows that proper assembly of the R-spine and Shell is essential for maintaining kinase activity. Structural analysis of the 172 known structures of EPKs without bound ligands led to the identification of four inactive conformations that correlate with the disassembly of the R-spine. Understanding the molecular elements involved in the regulation of kinase activity and the identification of these diverse groups of inactive conformations should aid the design of more specific therapeutic EPK inhibitors.

25 July 2023 in Immunological Reviews
Verified
Journal Article
Closed access
NENoah Earland
Noah Earland
WZWubing Zhang
Wubing Zhang
AUAbul Usmani
Abul Usmani
ANAishwarya Nene
Aishwarya Nene
ABAntonella Bacchiocchi
Antonella Bacchiocchi
ANAaron M. Newman
Aaron M. Newman

5 January 2017 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
ANAishwarya Nene
Aishwarya Nene
CHChe-Hong https://profiles.stanford.edu/che-hong-chen
Che-Hong https://profiles.stanford.edu/che-hong-chen
MDMarie-Hélène Disatnik
Marie-Hélène Disatnik
LCLeslie Cruz
Leslie Cruz
DMDaria Mochly-Rosen
Daria Mochly-Rosen
Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is a key enzyme for the metabolism of many toxic aldehydes such as acetaldehyde, derived from alcohol drinking, and 4HNE, an oxidative stress-derived lipid peroxidation aldehyde. Post-translational enhancement of ALDH2 activity can be achieved by serine/threonine phosphorylation by epsilon protein kinase C (εPKC). Elevated ALDH2 is beneficial in reducing injury following myocardial infarction, stroke and other oxidative stress and aldehyde toxicity-related diseases. We have previously identified three εPKC phosphorylation sites, threonine 185 (T185), serine 279 (S279) and threonine 412 (T412), on ALDH2. Here we further characterized the role and contribution of each phosphorylation site to the enhancement of enzymatic activity by εPKC. Each individual phosphorylation site was mutated to a negatively charged amino acid, glutamate, to mimic a phosphorylation, or to a non-phosphorylatable amino acid, alanine. ALDH2 enzyme activities and protection against 4HNE inactivation were measured in the presence or absence of εPKC phosphorylation in vitro. Coevolution of ALDH2 and its εPKC phosphorylation sites was delineated by multiple sequence alignments among a diverse range of species and within the ALDH multigene family. We identified S279 as a critical εPKC phosphorylation site in the activation of ALDH2. The critical catalytic site, cysteine 302 (C302) of ALDH2 is susceptible to adduct formation by reactive aldehyde, 4HNE, which readily renders the enzyme inactive. We show that phosphomimetic mutations of T185E, S279E and T412E confer protection of ALDH2 against 4HNE-induced inactivation, indicating that phosphorylation on these three sites by εPKC likely also protects the enzyme against reactive aldehydes. Finally, we demonstrate that the three ALDH2 phosphorylation sites co-evolved with εPKC over a wide range of species. Alignment of 18 human ALDH isozymes, indicates that T185 and S279 are unique ALDH2, εPKC specific phosphorylation sites, while T412 is found in other ALDH isozymes. We further identified three highly conserved serine/threonine residues (T384, T433 and S471) in all 18 ALDH isozymes that may play an important phosphorylation-mediated regulatory role in this important family of detoxifying enzymes. εPKC phosphorylation and its coevolution with ALDH2 play an important role in the regulation and protection of ALDH2 enzyme activity.

1 October 2025 in Hypertension
Verified
Journal Article
Closed access
ANAishwarya Nene
Aishwarya Nene
DLDana Lee
Dana Lee
OAOlayinka Agboola
Olayinka Agboola
JHJeph Herrin
Jeph Herrin
OOOyere K. Onuma
Oyere K. Onuma
ESErica S. Spatz
Erica S. Spatz
BACKGROUND: A hypertensive response to exercise unmasks hypertension and is associated with future cardiovascular events. Yet, there is heterogeneity in blood pressure response patterns to exercise by age and sex, and some high-risk trajectories may go undetected if only focusing on peak blood pressure. METHODS: We analyzed blood pressure data from 13 945 patients who underwent a Bruce protocol exercise tolerance test between 2016 and 2020, including the rate of change across stages. We used latent class analysis to identify distinct blood pressure trajectories and assessed their association with individual and composite outcomes of myocardial infarction, stroke, heart failure, revascularization, and death. RESULTS: Women had lower mean systolic and diastolic blood pressure at rest (128 mm Hg versus 132 mm Hg; 78 mm Hg versus 80 mm Hg) and through stages 1 to 3 of the Bruce protocol (stage 1: 140 mm Hg versus 144 mm Hg; 78 mm Hg versus 80 mm Hg; stage 2: 153 mm Hg versus 157 mm Hg; 79 mm Hg versus 81 mm Hg; stage 3: 159 mm Hg versus 167 mm Hg; 80 mm Hg versus 82 mm Hg). Systolic blood pressure increased more slowly in women. Three distinct systolic blood pressure trajectories emerged, with steeper trajectories associated with older populations and men. Systolic Classes II and III, characterized as an elevated baseline and a gradual rise (Class II) and a steep rise (Class III) with exercise, were associated with cardiovascular outcomes. Yet, only 1.4% and 34% of patients in Class II and III, respectively, met traditional criteria for hypertensive response to exercise, suggesting missed opportunities for prevention and treatment. CONCLUSIONS: Blood pressure response to exercise varies by sex; models incorporating trajectories of blood pressure could more fully capture individuals at higher risk for future cardiovascular events.